Although it is well documented that p53 undergoes a variety of posttranslational modifications that lead to the stabilization/destabilization of this protein in cancer cells, how p53 is activated in ATII cells in the fibrotic lung [22,23] is unclear. This evidence concerns the gene TP53 and cancer.